2|0|Public
50|$|The {{target of}} <b>votumumab</b> is CTAA16.88, {{a complex of}} cytokeratin polypeptides in the {{molecular}} weight range of 35 to 43 kDa, which is expressed in colorectal tumors.|$|E
50|$|Technetium (99mTc) <b>votumumab</b> (trade name HumaSPECT) {{is a human}} {{monoclonal}} antibody labelled with the radionuclide technetium-99m. It was developed {{for the detection of}} colorectal tumors, but has never been marketed.|$|E

